Pernix Therapeutics (PTX) Announces Significant Data from Silenor Phase IV vs. Zolpidem
Tweet Send to a Friend
Pernix Therapeutics Holdings, Inc. (Nasdaq: PTX) announced positive final results from a Phase IV Study assessing the effects of nighttime ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
